We are live on ! Find out more
VIAV icon

Viavi Solutions

227 hedge funds and large institutions have $1.36B invested in Viavi Solutions in 2016 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 83 increasing their positions, 53 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $3.96M | Put options by funds: $1.83M

57% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 53

11% more capital invested

Capital invested by funds: $1.23B → $1.36B (+$130M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 41

3% less funds holding

Funds holding: 233227 (-6)

Holders
227
Holders Change
-6
Holders Change %
-2.58%
% of All Funds
6.03%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
38
Increased
83
Reduced
53
Closed
41
Calls
$3.96M
Puts
$1.83M
Net Calls
+$2.14M
Net Calls Change
+$3.89M

VIAV Hedge Fund Activity: Q1 2016 in Review

227 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Viavi Solutions (VIAV) for Q1 2016, worth a combined $1.36B — up 11% from $1.23B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of VIAV and 38 opened new positions — a net loss of 3 holders — while 53 trimmed existing stakes and 83 added.

The largest buyer was Morgan Stanley, adding an estimated $22.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $51.8M.

  • 227 institutional investors held Viavi Solutions (VIAV) as of Q1 2016, down from 233 in Q4 2015.
  • Funds reported $1.36B of Viavi Solutions stock for Q1 2016, up 11% quarter-over-quarter.
  • 38 funds opened new Viavi Solutions positions in Q1 2016 and 41 closed out, a net change of -3 holders.
  • The largest Viavi Solutions buyer in Q1 2016 was Morgan Stanley, an estimated $22.9M added.
  • The largest Viavi Solutions seller in Q1 2016 was T. Rowe Price Associates, an estimated $51.8M sold.

Based on aggregated 13F filings for Q1 2016.